{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T15:50:29Z","timestamp":1762876229791,"version":"3.37.3"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T00:00:00Z","timestamp":1595289600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Drug Investig"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1007\/s40261-020-00952-0","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T08:04:08Z","timestamp":1595318648000},"page":"883-889","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Facial Paralysis Following Influenza Vaccination: A Disproportionality Analysis Using the Vaccine Adverse Event Reporting System Database"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9609-0199","authenticated-orcid":false,"given":"Ashwin","family":"Kamath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1995-5689","authenticated-orcid":false,"given":"Nivedita","family":"Maity","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9193-6864","authenticated-orcid":false,"given":"Manel Arjun","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,21]]},"reference":[{"issue":"4","key":"952_CR1","doi-asserted-by":"publisher","first-page":"e0153003","DOI":"10.1371\/journal.pone.0153003","volume":"11","author":"S Hirve","year":"2016","unstructured":"Hirve S, Newman LP, Paget J, et al. Influenza seasonality in the tropics and subtropics\u2014when to vaccinate? PLoS ONE. 2016;11(4):e0153003.","journal-title":"PLoS ONE"},{"key":"952_CR2","unstructured":"World Health Organization. Influenza (seasonal) fact sheet. World Health Organization [online]. https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/influenza-(seasonal). Accessed 17 July 2020."},{"issue":"4 Suppl","key":"952_CR3","doi-asserted-by":"publisher","first-page":"e10","DOI":"10.1097\/CCM.0b013e3181ceb25b","volume":"38","author":"DM Morens","year":"2010","unstructured":"Morens DM, Taubenberger JK, Harvey HA, Memoli MJ. The 1918 influenza pandemic: lessons for 2009 and the future. Crit Care Med. 2010;38(4 Suppl):e10.","journal-title":"Crit Care Med"},{"key":"952_CR4","unstructured":"CDC Seasonal Flu Vaccine Effectiveness Studies. Atlanta: Centers for Disease Control and Prevention. Available from:\u00a0https:\/\/www.cdc.gov\/flu\/vaccines-work\/effectiveness-studies.htm. Accessed 21 June 2020."},{"issue":"Suppl 1","key":"952_CR5","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1093\/infdis\/jiy633","volume":"219","author":"CI Paules","year":"2019","unstructured":"Paules CI, Fauci AS. Influenza vaccines: good, but we can do better. J Infect Dis. 2019;219(Suppl 1):S1\u2013S4.","journal-title":"J Infect Dis"},{"key":"952_CR6","unstructured":"Seasonal Influenza: Guidelines for Vaccination with Influenza Vaccine. New Delhi: Ministry of Health and Family Welfare, Directorate General of Health Services. https:\/\/main.mohfw.gov.in\/sites\/default\/files\/Seasonal%20Influenza%20-%20Guidelines%20for%20vaccination%20with%20Influenza%20Vaccine%20%28updated%29.pdf.\u00a0Accessed 10 Jan 2020."},{"key":"952_CR7","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1007\/s15010-008-8200-2","volume":"37","author":"S Wicker","year":"2009","unstructured":"Wicker S, Rabenau HF, Doerr HW, Allwinn R. Influenza vaccination compliance among health care workers in a German university hospital. Infection. 2009;37:197\u2013202.","journal-title":"Infection"},{"key":"952_CR8","volume-title":"UpToDate","author":"PL Hibberd","year":"2019","unstructured":"Hibberd PL. Seasonal influenza vaccination in adults. In: Post TW, editor. UpToDate. Waltham: UpToDate; 2019."},{"issue":"20","key":"952_CR9","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1001\/jama.292.20.2478","volume":"292","author":"P Haber","year":"2004","unstructured":"Haber P, DeStefano F, Angulo FJ, Iskander J, Shadomy SV, Weintraub E, Chen RT. Guillain\u2013Barr\u00e9 syndrome following influenza vaccination. JAMA. 2004;292(20):2478\u201381.","journal-title":"JAMA"},{"key":"952_CR10","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/01.cnd.0000245215.86174.79","volume":"8","author":"P Kelkar","year":"2006","unstructured":"Kelkar P. Chronic inflammatory demyelinating polyneuropathy (CIDP) with rapid progression after influenza vaccination: a report of three cases. J Clin Neuromuscul Dis. 2006;8:20\u20135.","journal-title":"J Clin Neuromuscul Dis"},{"key":"952_CR11","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s12883-016-0598-z","volume":"16","author":"E Alcalde-Cabero","year":"2016","unstructured":"Alcalde-Cabero E, Almaz\u00e1n-Isla J, Garc\u00eda L\u00f3pez FJ, et al. Guillain-Barr\u00e9 syndrome following the 2009 pandemic monovalent and seasonal trivalent influenza vaccination campaigns in Spain from 2009 to 2011: outcomes from active surveillance by a neurologist network, and records from a country-wide hospital discharge database. BMC Neurol. 2016;16:75.","journal-title":"BMC Neurol"},{"key":"952_CR12","doi-asserted-by":"publisher","first-page":"768","DOI":"10.3389\/fneur.2019.00768","volume":"10","author":"KH Chang","year":"2019","unstructured":"Chang KH, Lyu RK, Lin WT, Huang YT, Lin HS, Chang SH. Gulllain\u2013Barre syndrome after trivalent influenza vaccination in adults. Front Neurol. 2019;10:768.","journal-title":"Front Neurol"},{"key":"952_CR13","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1002\/pds.998","volume":"13","author":"W Zhou","year":"2004","unstructured":"Zhou W, Pool V, DeStefano F, et al. A potential signal of Bell\u2019s palsy after parenteral inactivated influenza vaccines: Reports to the Vaccine Adverse Event Reporting System (VAERS)-United States, 1991\u20132001. Pharmacoepidemiol Drug Saf. 2004;13:505\u201310.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"952_CR14","unstructured":"Committee to Review Adverse Effects of Vaccines; Institute of Medicine; Stratton K, Ford A, Rusch E, et al., editors. Adverse Effects of Vaccines: Evidence and Causality. Washington (DC): National Academies Press (US); 2011 Aug 25. 6, Influenza Vaccine. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK190013\/."},{"key":"952_CR15","doi-asserted-by":"publisher","first-page":"d5956","DOI":"10.1136\/bmj.d5956","volume":"343","author":"C Bardage","year":"2011","unstructured":"Bardage C, Persson I, Ortqvist A, Bergman U, Ludvigsson JF, Granath F. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. BMJ. 2011;343:d5956.","journal-title":"BMJ"},{"issue":"12","key":"952_CR16","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1016\/j.vaccine.2012.01.013","volume":"30","author":"WT Huang","year":"2012","unstructured":"Huang WT, Huang WI, Huang YW, Hsu CW, Chuang JH. The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: a capture-recapture analysis. Vaccine. 2012;30(12):2168\u201372.","journal-title":"Vaccine"},{"issue":"9","key":"952_CR17","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1093\/aje\/kws011","volume":"175","author":"A Rowhani-Rahbar","year":"2012","unstructured":"Rowhani-Rahbar A, Klein NP, Lewis N, et al. Immunization and Bell's palsy in children: a case-centered analysis. Am J Epidemiol. 2012;175(9):878\u201385.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"952_CR18","doi-asserted-by":"publisher","first-page":"e0175539","DOI":"10.1371\/journal.pone.0175539","volume":"12","author":"L Wijnans","year":"2017","unstructured":"Wijnans L, Dodd CN, Weibel D, Sturkenboom M. Bell's palsy and influenza(H1N1)pdm09 containing vaccines: a self-controlled case series. PLoS ONE. 2017;12(5):e0175539.","journal-title":"PLoS ONE"},{"issue":"8","key":"952_CR19","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s12325-018-0747-4","volume":"35","author":"S de Lusignan","year":"2018","unstructured":"de Lusignan S, Dos Santos G, Byford R, et al. Enhanced safety surveillance of seasonal quadrivalent influenza vaccines in english primary care: interim analysis. Adv Ther. 2018;35(8):1199\u2013214.","journal-title":"Adv Ther"},{"issue":"9","key":"952_CR20","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.1080\/21645515.2019.1581538","volume":"15","author":"S Gandhi-Banga","year":"2019","unstructured":"Gandhi-Banga S, Chabanon AL, Eymin C, Caroe T, Butler K, Moureau A. Enhanced passive safety surveillance of three marketed influenza vaccines in the UK and the Republic of Ireland during the 2017\/18 season. Hum Vaccin Immunother. 2019;15(9):2154\u20138.","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"952_CR21","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1080\/21645515.2019.1565258","volume":"15","author":"S de Lusignan","year":"2019","unstructured":"de Lusignan S, Ferreira F, Damaso S, et al. Enhanced passive surveillance of influenza vaccination in England, 2016\u20132017\u2014an observational study using an adverse events reporting card. Hum Vaccin Immunother. 2019;15(5):1048\u201359.","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"952_CR22","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1007\/s40264-019-00893-4","volume":"43","author":"G Dos Santos","year":"2020","unstructured":"Dos Santos G, Nguyen BY, Damaso S, et al. Brand-specific enhanced safety surveillance of GSK's quadrivalent seasonal influenza vaccine in Belgium, Germany and Spain for the 2018\/2019 season. Drug Saf. 2020;43(3):265\u201379.","journal-title":"Drug Saf"},{"issue":"15","key":"952_CR23","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1016\/j.vaccine.2016.05.023","volume":"35","author":"Brighton Collaboration Bell's Palsy Working Group","year":"2017","unstructured":"Brighton Collaboration Bell's Palsy Working Group. Facial nerve palsy including Bell's palsy: case definitions and guidelines for collection, analysis, and presentation of immunisation safety data. Vaccine. 2017;35(15):1972\u201383.","journal-title":"Vaccine"},{"issue":"36","key":"952_CR24","doi-asserted-by":"publisher","first-page":"4398","DOI":"10.1016\/j.vaccine.2015.07.035","volume":"33","author":"TT Shimabukuro","year":"2015","unstructured":"Shimabukuro TT, Nguyen M, Martin D, DeStefano F. Safety monitoring in the Vaccine Adverse Event Reporting System (VAERS). Vaccine. 2015;33(36):4398\u2013405.","journal-title":"Vaccine"},{"issue":"6","key":"952_CR25","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1111\/j.1365-2125.2011.04037.x","volume":"72","author":"JL Montastruc","year":"2011","unstructured":"Montastruc JL, Sommet A, Bagheri H, Lapeyre-Mestre M. Benefits and strengths of the disproportionality analysis for identification of adverse drug reactions in a pharmacovigilance database. Br J Clin Pharmacol. 2011;72(6):905\u20138.","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"952_CR26","doi-asserted-by":"publisher","first-page":"92","DOI":"10.5491\/SHAW.2012.3.2.92","volume":"3","author":"V Bonneterre","year":"2012","unstructured":"Bonneterre V, Bicout DJ, de Gaudemaris R. Application of pharmacovigilance methods in occupational health surveillance: comparison of seven disproportionality metrics. Saf Health Work. 2012;3(2):92\u2013100.","journal-title":"Saf Health Work"},{"issue":"8","key":"952_CR27","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1002\/pds.1002","volume":"13","author":"P Waller","year":"2004","unstructured":"Waller P, van Puijenbroek E, Egberts A, Evans S. The reporting odds ratio versus the proportional reporting ratio: 'deuce'. Pharmacoepidemiol Drug Saf. 2004;13(8):525\u20138.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"6","key":"952_CR28","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1002\/pds.677","volume":"10","author":"SJ Evans","year":"2001","unstructured":"Evans SJ, Waller PC, Davis S. Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports. Pharmacoepidemiol Drug Saf. 2001;10(6):483\u20136.","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"952_CR29","unstructured":"European Medicines Agency. Screening for adverse reactions in EudraVigilance; 2016. https:\/\/www.ema.europa.eu\/en\/documents\/other\/screening-adverse-reactions-eudravigilance_en.pdf.\u00a0Accessed 21 June 2020."},{"issue":"1\u20133","key":"952_CR30","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0169-409X(01)00169-7","volume":"51","author":"EA McNeela","year":"2001","unstructured":"McNeela EA, Mills KH. Manipulating the immune system: humoral versus cell-mediated immunity. Adv Drug Deliv Rev. 2001;51(1\u20133):43\u2013544.","journal-title":"Adv Drug Deliv Rev"},{"issue":"9","key":"952_CR31","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1056\/NEJMp048006","volume":"350","author":"RB Couch","year":"2004","unstructured":"Couch RB. Nasal vaccination, Escherichiacoli enterotoxin, and Bell's palsy. N Engl J Med. 2004;350(9):860\u20131.","journal-title":"N Engl J Med"},{"issue":"22","key":"952_CR32","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1016\/j.vaccine.2016.03.048","volume":"34","author":"P Haber","year":"2016","unstructured":"Haber P, Moro PL, Lewis P, Woo EJ, Jankosky C, Cano M. Post-licensure surveillance of quadrivalent inactivated influenza (IIV4) vaccine in the United States, Vaccine Adverse Event Reporting System (VAERS), July 1, 2013\u2013May 31, 2015. Vaccine. 2016;34(22):2507\u201312.","journal-title":"Vaccine"},{"key":"952_CR33","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1056\/NEJMoa030595","volume":"350","author":"M Mutsch","year":"2004","unstructured":"Mutsch M, Zhou W, Rhodes P, et al. Use of the inactivated intranasal influenza vaccine and the risk of Bell\u2019s palsy in Switzerland. N Engl J Med. 2004;350:896\u2013903.","journal-title":"N Engl J Med"}],"container-title":["Clinical Drug Investigation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-020-00952-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40261-020-00952-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40261-020-00952-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T23:41:03Z","timestamp":1626824463000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40261-020-00952-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,21]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["952"],"URL":"https:\/\/doi.org\/10.1007\/s40261-020-00952-0","relation":{},"ISSN":["1173-2563","1179-1918"],"issn-type":[{"type":"print","value":"1173-2563"},{"type":"electronic","value":"1179-1918"}],"subject":[],"published":{"date-parts":[[2020,7,21]]},"assertion":[{"value":"21 July 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors have no conflicts of interest to declare.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The study protocol was approved by Kasturba Medical College Institutional Ethics Committee.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All data pertaining to this study is available in the CDC and\u00a0US FDA-managed Vaccine Adverse Event Reporting System, a public database.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}